https://www.selleckchem.com/pe....ptide/pki-14-22-amid
To assess the relative efficacy and safety of tofacitinib administration (5 and 10mg) twice daily in psoriasis patients. Randomized controlled trials (RCTs) examining the efficacy and safety of tofacitinib in psoriasis patients were included in this network meta-analysis. A Bayesian network meta-analysis was performed to combine the direct and indirect evidence from the RCTs. Five RCTs, including 3,265 patients, met the inclusion criteria. The 75% or more reduction in Psoriasis Area and Severity Index (PASI75) respo
Like
Comment
Share
